Fibrosi cistica (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fibrosi cistica" in Italian language version.

refsWebsite

Global rank Italian rank

61nih.gov

4^th place

9^th place

52doi.org

2^nd place

7^th place

22archive.org

6^th place

8^th place

21oadoi.org

799^th place

22^nd place

12web.archive.org

1^st place

4google.ca

838^th place

542^nd place

1nhs.uk

1,989^th place

3,151^st place

1msdmanuals.com

4,047^th place

1,347^th place

1cff.org

low place

1science.ca

low place

1archive.is

87^th place

low place

1eje-online.org

low place

1consultantlive.com

low place

1elsevier.es

7,063^rd place

low place

1scielo.br

1,606^th place

2,745^th place

1oxfordjournals.org

1,389^th place

732^nd place

1metapress.com

8,671^st place

low place

1sibioc.it

low place

1sifc.it

low place

1elsevier.com

610^th place

820^th place

1cftr2.org

low place

1fibrosicisticaricerca.it

low place

1testfibrosicistica.it

low place

1atsjournals.org

low place

archive.is

Quinton PM, Cystic fibrosis: lessons from the sweat gland, in Physiology (Bethesda), vol. 22, n. 3, giugno 2007, pp. 212–25, DOI:10.1152/physiol.00041.2006, PMID 17557942. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 15 aprile 2013).

archive.org

Sant'Agnese PA, Darling RC, Perera GA, Shea E, Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease, in Pediatrics, vol. 12, n. 5, novembre 1953, pp. 549–63, PMID 13111855.
Mitchell, Richard Sheppard; Kumar, Vinay; Robbins, Stanley L.; Abbas, Abul K.; Fausto, Nelson, Robbins basic pathology, Saunders/Elsevier, 2007, ISBN 1-4160-2973-7.
Rosenstein BJ, Cutting GR, The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel, in J. Pediatr., vol. 132, n. 4, aprile 1998, pp. 589–95, DOI:10.1016/S0022-3476(98)70344-0, PMID 9580754.
Hamosh A, FitzSimmons SC, Macek M, Knowles MR, Rosenstein BJ, Cutting GR, Comparison of the clinical manifestations of cystic fibrosis in black and white patients, in J. Pediatr., vol. 132, n. 2, febbraio 1998, pp. 255–9, DOI:10.1016/S0022-3476(98)70441-X, PMID 9506637.
Coakley RD, Sun H, Clunes LA, et al., 17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia, in J. Clin. Invest., vol. 118, n. 12, dicembre 2008, pp. 4025–35, DOI:10.1172/JCI33893, PMC 2582929, PMID 19033671.
Verma N, Bush A, Buchdahl R, Is there still a gender gap in cystic fibrosis?, in Chest, vol. 128, n. 4, ottobre 2005, pp. 2824–34, DOI:10.1378/chest.128.4.2824, PMID 16236961.
Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W, Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality, in Diabetes Care, vol. 32, n. 9, settembre 2009, pp. 1626–31, DOI:10.2337/dc09-0586, PMC 2732133, PMID 19542209.
Kere J, Savilahti E, Norio R, Estivill X, de la Chapelle A, Cystic fibrosis mutation delta F508 in Finland: other mutations predominate, in Hum. Genet., vol. 85, n. 4, settembre 1990, pp. 413–5, DOI:10.1007/BF02428286, PMID 2210753.
De Lisle RC, Pass the bicarb: the importance of HCO3- for mucin release, in J. Clin. Invest., vol. 119, n. 9, settembre 2009, pp. 2535–7, DOI:10.1172/JCI40598, PMC 2735941, PMID 19726878.
Blackman SM, Deering-Brose R, McWilliams R, et al., Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis, in Gastroenterology, vol. 131, n. 4, ottobre 2006, pp. 1030–9, DOI:10.1053/j.gastro.2006.07.016, PMC 1764617, PMID 17030173.
Eggermont E, De Boeck K, Small-intestinal abnormalities in cystic fibrosis patients, in Eur. J. Pediatr., vol. 150, n. 12, ottobre 1991, pp. 824–8, DOI:10.1007/BF01954999, PMID 1743211.
Malfroot A, Dab I, New insights on gastro-esophageal reflux in cystic fibrosis by longitudinal follow up, in Arch. Dis. Child., vol. 66, n. 11, novembre 1991, pp. 1339–45, DOI:10.1136/adc.66.11.1339, PMC 1793275, PMID 1755649.
Williams SG, Westaby D, Tanner MS, Mowat AP, Liver and biliary problems in cystic fibrosis, in Br. Med. Bull., vol. 48, n. 4, ottobre 1992, pp. 877–92, PMID 1458306.
Moran A, Pyzdrowski KL, Weinreb J, et al., Insulin sensitivity in cystic fibrosis, in Diabetes, vol. 43, n. 8, agosto 1994, pp. 1020–6, DOI:10.2337/diabetes.43.8.1020, PMID 8039595.
Pitts-Tucker TJ, Miller MG, Littlewood JM, Finger clubbing in cystic fibrosis, in Arch. Dis. Child., vol. 61, n. 6, giugno 1986, pp. 576–9, DOI:10.1136/adc.61.6.576, PMC 1777828, PMID 3488032.
McCallum TJ, Milunsky JM, Cunningham DL, Harris DH, Maher TA, Oates RD, Fertility in men with cystic fibrosis: an update on current surgical practices and outcomes, in Chest, vol. 118, n. 4, ottobre 2000, pp. 1059–62, DOI:10.1378/chest.118.4.1059, PMID 11035677.
Gilljam M, Antoniou M, Shin J, Dupuis A, Corey M, Tullis DE, Pregnancy in cystic fibrosis. Fetal and maternal outcome, in Chest, vol. 118, n. 1, luglio 2000, pp. 85–91, DOI:10.1378/chest.118.1.85, PMID 10893364.
Ross LF, Newborn screening for cystic fibrosis: a lesson in public health disparities, in The Journal of Pediatrics, vol. 153, n. 3, settembre 2008, pp. 308–13, DOI:10.1016/j.jpeds.2008.04.061, PMC 2569148, PMID 18718257.
Elias S, Annas GJ, Simpson JL, Carrier screening for cystic fibrosis: implications for obstetric and gynecologic practice, in Am. J. Obstet. Gynecol., vol. 164, n. 4, aprile 1991, pp. 1077–83, PMID 2014829.
Fridell JA, Vianna R, Kwo PY, et al., Simultaneous liver and pancreas transplantation in patients with cystic fibrosis, in Transplant. Proc., vol. 37, n. 8, ottobre 2005, pp. 3567–9, DOI:10.1016/j.transproceed.2005.09.091, PMID 16298663.
Hardin DS, Rice J, Ahn C, et al., Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition, in J. Pediatr., vol. 146, n. 3, marzo 2005, pp. 324–8, DOI:10.1016/j.jpeds.2004.10.037, PMID 15756212.
Phillipson GT, Petrucco OM, Matthews CD, Congenital bilateral absence of the vas deferens, cystic fibrosis mutation analysis and intracytoplasmic sperm injection, in Hum. Reprod., vol. 15, n. 2, febbraio 2000, pp. 431–5, DOI:10.1093/humrep/15.2.431, PMID 10655317.

atsjournals.org

ajrccm.atsjournals.org

Tan KH, Mulheran M, Knox AJ, Smyth AR, Aminoglycoside prescribing and surveillance in cystic fibrosis, in Am. J. Respir. Crit. Care Med., vol. 167, n. 6, marzo 2003, pp. 819–23, DOI:10.1164/rccm.200109-012CC, PMID 12623858.

cff.org

Cystic Fibrosis Foundation – Genetic Carrier Testing Archiviato il 23 marzo 2010 in Internet Archive. Updated 07/09/07

cftr2.org

US CF Foundation, Johns Hopkins University, The Hospital for Sick Children, The Clinical and Functional TRanslation of CFTR (CFTR2), su cftr2.org.

consultantlive.com

Reaves J, Wallace G. Unexplained bruising: weighing the pros and cons of possible causes. Consultant for Pediatricians. 2010;9:201–202.

doi.org

dx.doi.org

LC. Tsui, Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium., in Hum Mutat, vol. 1, n. 3, 1992, pp. 197-203, DOI:10.1002/humu.1380010304, PMID 1284534.
Araújo FG, Novaes FC, Santos NP, et al., Prevalence of deltaF508, G551D, G542X, and R553X mutations among cystic fibrosis patients in the North of Brazil, in Braz. J. Med. Biol. Res., vol. 38, n. 1, gennaio 2005, pp. 11–5, DOI:10.1590/S0100-879X2005000100003, PMID 15665983.
Rosenstein BJ, Cutting GR, The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel, in J. Pediatr., vol. 132, n. 4, aprile 1998, pp. 589–95, DOI:10.1016/S0022-3476(98)70344-0, PMID 9580754.
Hamosh A, FitzSimmons SC, Macek M, Knowles MR, Rosenstein BJ, Cutting GR, Comparison of the clinical manifestations of cystic fibrosis in black and white patients, in J. Pediatr., vol. 132, n. 2, febbraio 1998, pp. 255–9, DOI:10.1016/S0022-3476(98)70441-X, PMID 9506637.
Hytönen M, Patjas M, Vento SI, et al., Cystic fibrosis gene mutations deltaF508 and 394delTT in patients with chronic sinusitis in Finland, in Acta Otolaryngol., vol. 121, n. 8, dicembre 2001, pp. 945–7, DOI:10.1080/000164801317166835, PMID 11813900.
Coakley RD, Sun H, Clunes LA, et al., 17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia, in J. Clin. Invest., vol. 118, n. 12, dicembre 2008, pp. 4025–35, DOI:10.1172/JCI33893, PMC 2582929, PMID 19033671.
Verma N, Bush A, Buchdahl R, Is there still a gender gap in cystic fibrosis?, in Chest, vol. 128, n. 4, ottobre 2005, pp. 2824–34, DOI:10.1378/chest.128.4.2824, PMID 16236961.
Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W, Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality, in Diabetes Care, vol. 32, n. 9, settembre 2009, pp. 1626–31, DOI:10.2337/dc09-0586, PMC 2732133, PMID 19542209.
Kere J, Savilahti E, Norio R, Estivill X, de la Chapelle A, Cystic fibrosis mutation delta F508 in Finland: other mutations predominate, in Hum. Genet., vol. 85, n. 4, settembre 1990, pp. 413–5, DOI:10.1007/BF02428286, PMID 2210753.
Bobadilla JL, Macek M, Fine JP, Farrell PM, Cystic fibrosis: a worldwide analysis of CFTR mutations—correlation with incidence data and application to screening, in Hum. Mutat., vol. 19, n. 6, giugno 2002, pp. 575–606, DOI:10.1002/humu.10041, PMID 12007216.
Rowe SM, Miller S, Sorscher EJ, Cystic fibrosis, in The New England Journal of Medicine, vol. 352, n. 19, maggio 2005, pp. 1992–2001, DOI:10.1056/NEJMra043184, PMID 15888700.
EF. McKone, SS. Emerson; KL. Edwards; ML. Aitken, Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study., in Lancet, vol. 361, n. 9370, maggio 2003, pp. 1671-6, DOI:10.1016/S0140-6736(03)13368-5, PMID 12767731.
Quinton PM, Cystic fibrosis: lessons from the sweat gland, in Physiology (Bethesda), vol. 22, n. 3, giugno 2007, pp. 212–25, DOI:10.1152/physiol.00041.2006, PMID 17557942. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 15 aprile 2013).
Hardin DS, GH improves growth and clinical status in children with cystic fibrosis – a review of published studies, in Eur. J. Endocrinol., 151 Suppl 1, agosto 2004, pp. S81–5, DOI:10.1530/eje.0.151S081, PMID 15339250.
De Lisle RC, Pass the bicarb: the importance of HCO3- for mucin release, in J. Clin. Invest., vol. 119, n. 9, settembre 2009, pp. 2535–7, DOI:10.1172/JCI40598, PMC 2735941, PMID 19726878.
O'Malley CA, Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist (PDF), in Respir Care, vol. 54, n. 5, maggio 2009, pp. 641–57, DOI:10.4187/aarc0446, PMID 19393108. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 15 luglio 2011).
Blackman SM, Deering-Brose R, McWilliams R, et al., Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis, in Gastroenterology, vol. 131, n. 4, ottobre 2006, pp. 1030–9, DOI:10.1053/j.gastro.2006.07.016, PMC 1764617, PMID 17030173.
Ratjen FA, Cystic fibrosis: pathogenesis and future treatment strategies (PDF), in Respir Care, vol. 54, n. 5, maggio 2009, pp. 595–605, DOI:10.4187/aarc0427, PMID 19393104. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 15 luglio 2011).
Flume PA, Mogayzel Jr PJ, Robinson KA, et al., Cystic Fibrosis Pulmonary Guidelines: Pulmonary Complications: Hemoptysis and Pneumothorax, in Am J Respir Crit Care Med, vol. 182, n. 3, marzo 2010, p. 298, DOI:10.1164/rccm.201002-0157OC, PMID 20299528.
(ES) Girón RM, Domingo D, Buendía B, Antón E, Ruiz-Velasco LM, Ancochea J, Nontuberculous mycobacteria in patients with cystic fibrosis ^{[collegamento interrotto]}, in Arch. Bronconeumol., vol. 41, n. 10, ottobre 2005, pp. 560–5, DOI:10.1016/S1579-2129(06)60283-8, PMID 16266669.
Ramsey B, Richardson MA, Impact of sinusitis in cystic fibrosis, in J. Allergy Clin. Immunol., vol. 90, 3 Pt 2, settembre 1992, pp. 547–52, DOI:10.1016/0091-6749(92)90183-3, PMID 1527348.
Franco LP, Camargos PA, Becker HM, Guimarães RE, Nasal endoscopic evaluation of children and adolescents with cystic fibrosis, in Braz J Otorhinolaryngol, vol. 75, n. 6, dicembre 2009, pp. 806–13, DOI:10.1590/S1808-86942009000600006, PMID 20209279.
Eggermont E, De Boeck K, Small-intestinal abnormalities in cystic fibrosis patients, in Eur. J. Pediatr., vol. 150, n. 12, ottobre 1991, pp. 824–8, DOI:10.1007/BF01954999, PMID 1743211.
Kulczycki LL, Shwachman H, Studies in cystic fibrosis of the pancreas; occurrence of rectal prolapse, in N. Engl. J. Med., vol. 259, n. 9, agosto 1958, pp. 409–12, DOI:10.1056/NEJM195808282590901, PMID 13578072.
Malfroot A, Dab I, New insights on gastro-esophageal reflux in cystic fibrosis by longitudinal follow up, in Arch. Dis. Child., vol. 66, n. 11, novembre 1991, pp. 1339–45, DOI:10.1136/adc.66.11.1339, PMC 1793275, PMID 1755649.
Colombo C, Russo MC, Zazzeron L, Romano G, Liver disease in cystic fibrosis, in J. Pediatr. Gastroenterol. Nutr., 43 Suppl 1, luglio 2006, pp. S49–55, DOI:10.1097/01.mpg.0000226390.02355.52, PMID 16819402.
Moran A, Pyzdrowski KL, Weinreb J, et al., Insulin sensitivity in cystic fibrosis, in Diabetes, vol. 43, n. 8, agosto 1994, pp. 1020–6, DOI:10.2337/diabetes.43.8.1020, PMID 8039595.
Alves Cde A, Aguiar RA, Alves AC, Santana MA, Diabetes mellitus in patients with cystic fibrosis, in J Bras Pneumol, vol. 33, n. 2, aprile 2007, pp. 213–21, DOI:10.1590/S1806-37132007000200017, PMID 17724542.
Haworth CS, Selby PL, Webb AK, et al., Low bone mineral density in adults with cystic fibrosis, in Thorax, vol. 54, n. 11, novembre 1999, pp. 961–7, DOI:10.1136/thx.54.11.961, PMC 1745400, PMID 10525552.
Pitts-Tucker TJ, Miller MG, Littlewood JM, Finger clubbing in cystic fibrosis, in Arch. Dis. Child., vol. 61, n. 6, giugno 1986, pp. 576–9, DOI:10.1136/adc.61.6.576, PMC 1777828, PMID 3488032.
McCallum TJ, Milunsky JM, Cunningham DL, Harris DH, Maher TA, Oates RD, Fertility in men with cystic fibrosis: an update on current surgical practices and outcomes, in Chest, vol. 118, n. 4, ottobre 2000, pp. 1059–62, DOI:10.1378/chest.118.4.1059, PMID 11035677.
Augarten A, Yahav Y, Kerem BS, et al., Congenital bilateral absence of vas deferens in the absence of cystic fibrosis, in Lancet, vol. 344, n. 8935, novembre 1994, pp. 1473–4, DOI:10.1016/S0140-6736(94)90292-5, PMID 7968122.
Gilljam M, Antoniou M, Shin J, Dupuis A, Corey M, Tullis DE, Pregnancy in cystic fibrosis. Fetal and maternal outcome, in Chest, vol. 118, n. 1, luglio 2000, pp. 85–91, DOI:10.1378/chest.118.1.85, PMID 10893364.
Davies JC, Alton EW, Bush A, Cystic fibrosis, in BMJ, vol. 335, n. 7632, dicembre 2007, pp. 1255–9, DOI:10.1136/bmj.39391.713229.AD, PMC 2137053, PMID 18079549.
Ross LF, Newborn screening for cystic fibrosis: a lesson in public health disparities, in The Journal of Pediatrics, vol. 153, n. 3, settembre 2008, pp. 308–13, DOI:10.1016/j.jpeds.2008.04.061, PMC 2569148, PMID 18718257.
BM Assael, Castellani C, Ocampo MB et al., Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years, in American Journal of Epidemiology, vol. 156, n. 5, settembre 2002, pp. 397–401, DOI:10.1093/aje/kwf064, PMID 12196308.
Stern RC, The diagnosis of cystic fibrosis, in N. Engl. J. Med., vol. 336, n. 7, febbraio 1997, pp. 487–91, DOI:10.1056/NEJM199702133360707, PMID 9017943.
(EN) Alessandra Coiana, Valeria Faa' e Daniela Carta, Preconceptional identification of cystic fibrosis carriers in the Sardinian population: A pilot screening program, in Journal of Cystic Fibrosis, vol. 10, n. 3, 2011-05, pp. 207–211, DOI:10.1016/j.jcf.2011.02.006. URL consultato il 22 maggio 2023.
Pai VB, Nahata MC, Efficacy and safety of aerosolized tobramycin in cystic fibrosis, in Pediatr. Pulmonol., vol. 32, n. 4, ottobre 2001, pp. 314–27, DOI:10.1002/ppul.1125, PMID 11568993.
Westerman EM, Le Brun PP, Touw DJ, Frijlink HW, Heijerman HG, Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study, in J. Cyst. Fibros., vol. 3, n. 1, marzo 2004, pp. 23–8, DOI:10.1016/j.jcf.2003.12.005, PMID 15463883.
McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB, Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis, in Am. J. Respir. Crit. Care Med., vol. 178, n. 9, novembre 2008, pp. 921–8, DOI:10.1164/rccm.200712-1804OC, PMC 2577727, PMID 18658109.
Hansen CR, Pressler T, Koch C, Høiby N, Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study, in J. Cyst. Fibros., vol. 4, n. 1, marzo 2005, pp. 35–40, DOI:10.1016/j.jcf.2004.09.001, PMID 15752679.
Tan KH, Mulheran M, Knox AJ, Smyth AR, Aminoglycoside prescribing and surveillance in cystic fibrosis, in Am. J. Respir. Crit. Care Med., vol. 167, n. 6, marzo 2003, pp. 819–23, DOI:10.1164/rccm.200109-012CC, PMID 12623858.
Fridell JA, Vianna R, Kwo PY, et al., Simultaneous liver and pancreas transplantation in patients with cystic fibrosis, in Transplant. Proc., vol. 37, n. 8, ottobre 2005, pp. 3567–9, DOI:10.1016/j.transproceed.2005.09.091, PMID 16298663.
Belkin RA, Henig NR, Singer LG, et al., Risk factors for death of patients with cystic fibrosis awaiting lung transplantation, in Am. J. Respir. Crit. Care Med., vol. 173, n. 6, marzo 2006, pp. 659–66, DOI:10.1164/rccm.200410-1369OC, PMC 2662949, PMID 16387803.
Alves CAD, Aguiar RA, Alves AC, Santana MA, Diabetes mellitus in patients with cystic fibrosis, in J Bras Pneumol, vol. 33, n. 2, aprile 2007, pp. 213–21, DOI:10.1590/S1806-37132007000200017, PMID 17724542.
Zirbes J, Milla CE, Cystic fibrosis related diabetes, in Paediatr Respir Rev, vol. 10, n. 3, settembre 2009, pp. 118–23; quiz 123, DOI:10.1016/j.prrv.2009.04.004, PMID 19651382.
Onady GM, Stolfi A, Insulin and oral agents for managing cystic fibrosis-related diabetes, in Gary M Onady (a cura di), Cochrane Database Syst Rev, n. 3, 2005, pp. CD004730, DOI:10.1002/14651858.CD004730.pub2, PMID 16034943.
Conwell LS, Chang AB, Bisphosphonates for osteoporosis in people with cystic fibrosis, in Cochrane Database Syst Rev, n. 4, 2012, pp. CD002010, DOI:10.1002/14651858.CD002010.pub3, PMID 22513903.
Hardin DS, Rice J, Ahn C, et al., Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition, in J. Pediatr., vol. 146, n. 3, marzo 2005, pp. 324–8, DOI:10.1016/j.jpeds.2004.10.037, PMID 15756212.
Marks SC, Kissner DG, Management of sinusitis in adult cystic fibrosis, in Am J Rhinol, vol. 11, n. 1, 1997, pp. 11–4, DOI:10.2500/105065897781446810, PMID 9065342.
Phillipson GT, Petrucco OM, Matthews CD, Congenital bilateral absence of the vas deferens, cystic fibrosis mutation analysis and intracytoplasmic sperm injection, in Hum. Reprod., vol. 15, n. 2, febbraio 2000, pp. 431–5, DOI:10.1093/humrep/15.2.431, PMID 10655317.

eje-online.org

Hardin DS, GH improves growth and clinical status in children with cystic fibrosis – a review of published studies, in Eur. J. Endocrinol., 151 Suppl 1, agosto 2004, pp. S81–5, DOI:10.1530/eje.0.151S081, PMID 15339250.

elsevier.com

linkinghub.elsevier.com

(EN) Alessandra Coiana, Valeria Faa' e Daniela Carta, Preconceptional identification of cystic fibrosis carriers in the Sardinian population: A pilot screening program, in Journal of Cystic Fibrosis, vol. 10, n. 3, 2011-05, pp. 207–211, DOI:10.1016/j.jcf.2011.02.006. URL consultato il 22 maggio 2023.

elsevier.es

(ES) Girón RM, Domingo D, Buendía B, Antón E, Ruiz-Velasco LM, Ancochea J, Nontuberculous mycobacteria in patients with cystic fibrosis ^{[collegamento interrotto]}, in Arch. Bronconeumol., vol. 41, n. 10, ottobre 2005, pp. 560–5, DOI:10.1016/S1579-2129(06)60283-8, PMID 16266669.

fibrosicisticaricerca.it

Fondazione Ricerca Fibrosi Cistica, su fibrosicisticaricerca.it.

google.ca

books.google.ca

Edward Tobias, Essential Medical Genetics, John Wiley & Sons, 2011, pp. 312, ISBN 1-118-29370-3.
[edited by] Ruth A. Hannon ... [et al., Porth pathophysiology : concepts of altered health states, 1st Canadian ed., Philadelphia, PA, Wolters Kluwer Health/Lippincott Williams & Wilkins, 2010, pp. 692, ISBN 978-1-60547-781-7.
Peter Russell, Biology : the dynamic science., 2nd ed., Belmont, CA, Brooks/Cole, Cengage Learning, 2011, pp. 304, ISBN 978-0-538-49372-7.
A.Y. Elzouki ... [et al., Textbook of clinical pediatrics, 2nd ed., Berlin, Springer, pp. 2214, ISBN 978-3-642-02201-2.

metapress.com

versita.metapress.com

Minarowski Ł, Sands D, Minarowska A, Karwowska A, Sulewska A, Gacko M, Chyczewska E. Thiocyanate concentration in saliva of cystic fibrosis patients. Folia Histochem Cytobiol. 2008;46(2):245-6. ^{[collegamento interrotto]}

msdmanuals.com

Fibrosi cistica - Pediatria, su Manuali MSD Edizione Professionisti. URL consultato il 2 febbraio 2022.

nhs.uk

(EN) Cystic fibrosis, su nhs.uk, 23 ottobre 2017. URL consultato il 2 febbraio 2022.

nih.gov

ncbi.nlm.nih.gov

Busch R, On the history of cystic fibrosis, in Acta Univ Carol Med (Praha), vol. 36, 1–4, 1990, pp. 13–5, PMID 2130674.
Sant'Agnese PA, Darling RC, Perera GA, Shea E, Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease, in Pediatrics, vol. 12, n. 5, novembre 1953, pp. 549–63, PMID 13111855.
LC. Tsui, Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium., in Hum Mutat, vol. 1, n. 3, 1992, pp. 197-203, DOI:10.1002/humu.1380010304, PMID 1284534.
LC. Tsui, The cystic fibrosis transmembrane conductance regulator gene., in Am J Respir Crit Care Med, vol. 151, 3 Pt 2, marzo 1995, pp. S47-53, PMID 7533605.
Araújo FG, Novaes FC, Santos NP, et al., Prevalence of deltaF508, G551D, G542X, and R553X mutations among cystic fibrosis patients in the North of Brazil, in Braz. J. Med. Biol. Res., vol. 38, n. 1, gennaio 2005, pp. 11–5, DOI:10.1590/S0100-879X2005000100003, PMID 15665983.
Rosenstein BJ, Cutting GR, The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel, in J. Pediatr., vol. 132, n. 4, aprile 1998, pp. 589–95, DOI:10.1016/S0022-3476(98)70344-0, PMID 9580754.
Hamosh A, FitzSimmons SC, Macek M, Knowles MR, Rosenstein BJ, Cutting GR, Comparison of the clinical manifestations of cystic fibrosis in black and white patients, in J. Pediatr., vol. 132, n. 2, febbraio 1998, pp. 255–9, DOI:10.1016/S0022-3476(98)70441-X, PMID 9506637.
Hytönen M, Patjas M, Vento SI, et al., Cystic fibrosis gene mutations deltaF508 and 394delTT in patients with chronic sinusitis in Finland, in Acta Otolaryngol., vol. 121, n. 8, dicembre 2001, pp. 945–7, DOI:10.1080/000164801317166835, PMID 11813900.
Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B, Gender gap in cystic fibrosis mortality, in Am. J. Epidemiol., vol. 145, n. 9, maggio 1997, pp. 794–803, PMID 9143209.
Coakley RD, Sun H, Clunes LA, et al., 17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia, in J. Clin. Invest., vol. 118, n. 12, dicembre 2008, pp. 4025–35, DOI:10.1172/JCI33893, PMC 2582929, PMID 19033671.
Verma N, Bush A, Buchdahl R, Is there still a gender gap in cystic fibrosis?, in Chest, vol. 128, n. 4, ottobre 2005, pp. 2824–34, DOI:10.1378/chest.128.4.2824, PMID 16236961.
Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W, Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality, in Diabetes Care, vol. 32, n. 9, settembre 2009, pp. 1626–31, DOI:10.2337/dc09-0586, PMC 2732133, PMID 19542209.
Kere J, Savilahti E, Norio R, Estivill X, de la Chapelle A, Cystic fibrosis mutation delta F508 in Finland: other mutations predominate, in Hum. Genet., vol. 85, n. 4, settembre 1990, pp. 413–5, DOI:10.1007/BF02428286, PMID 2210753.
Bobadilla JL, Macek M, Fine JP, Farrell PM, Cystic fibrosis: a worldwide analysis of CFTR mutations—correlation with incidence data and application to screening, in Hum. Mutat., vol. 19, n. 6, giugno 2002, pp. 575–606, DOI:10.1002/humu.10041, PMID 12007216.
Rowe SM, Miller S, Sorscher EJ, Cystic fibrosis, in The New England Journal of Medicine, vol. 352, n. 19, maggio 2005, pp. 1992–2001, DOI:10.1056/NEJMra043184, PMID 15888700.
EF. McKone, SS. Emerson; KL. Edwards; ML. Aitken, Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study., in Lancet, vol. 361, n. 9370, maggio 2003, pp. 1671-6, DOI:10.1016/S0140-6736(03)13368-5, PMID 12767731.
Quinton PM, Cystic fibrosis: lessons from the sweat gland, in Physiology (Bethesda), vol. 22, n. 3, giugno 2007, pp. 212–25, DOI:10.1152/physiol.00041.2006, PMID 17557942. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 15 aprile 2013).
Hardin DS, GH improves growth and clinical status in children with cystic fibrosis – a review of published studies, in Eur. J. Endocrinol., 151 Suppl 1, agosto 2004, pp. S81–5, DOI:10.1530/eje.0.151S081, PMID 15339250.
De Lisle RC, Pass the bicarb: the importance of HCO3- for mucin release, in J. Clin. Invest., vol. 119, n. 9, settembre 2009, pp. 2535–7, DOI:10.1172/JCI40598, PMC 2735941, PMID 19726878.
O'Malley CA, Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist (PDF), in Respir Care, vol. 54, n. 5, maggio 2009, pp. 641–57, DOI:10.4187/aarc0446, PMID 19393108. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 15 luglio 2011).
Makker K, Agarwal A, Sharma R, Oxidative stress & male infertility (PDF), in Indian J. Med. Res., vol. 129, n. 4, aprile 2009, pp. 357–67, PMID 19535829. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 5 luglio 2010).
Blackman SM, Deering-Brose R, McWilliams R, et al., Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis, in Gastroenterology, vol. 131, n. 4, ottobre 2006, pp. 1030–9, DOI:10.1053/j.gastro.2006.07.016, PMC 1764617, PMID 17030173.
Ratjen FA, Cystic fibrosis: pathogenesis and future treatment strategies (PDF), in Respir Care, vol. 54, n. 5, maggio 2009, pp. 595–605, DOI:10.4187/aarc0427, PMID 19393104. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 15 luglio 2011).
Flume PA, Mogayzel Jr PJ, Robinson KA, et al., Cystic Fibrosis Pulmonary Guidelines: Pulmonary Complications: Hemoptysis and Pneumothorax, in Am J Respir Crit Care Med, vol. 182, n. 3, marzo 2010, p. 298, DOI:10.1164/rccm.201002-0157OC, PMID 20299528.
(ES) Girón RM, Domingo D, Buendía B, Antón E, Ruiz-Velasco LM, Ancochea J, Nontuberculous mycobacteria in patients with cystic fibrosis ^{[collegamento interrotto]}, in Arch. Bronconeumol., vol. 41, n. 10, ottobre 2005, pp. 560–5, DOI:10.1016/S1579-2129(06)60283-8, PMID 16266669.
Maldonado M, Martínez A, Alobid I, Mullol J, The antrochoanal polyp, in Rhinology, vol. 42, n. 4, dicembre 2004, pp. 178–82, PMID 15626248.
Ramsey B, Richardson MA, Impact of sinusitis in cystic fibrosis, in J. Allergy Clin. Immunol., vol. 90, 3 Pt 2, settembre 1992, pp. 547–52, DOI:10.1016/0091-6749(92)90183-3, PMID 1527348.
Franco LP, Camargos PA, Becker HM, Guimarães RE, Nasal endoscopic evaluation of children and adolescents with cystic fibrosis, in Braz J Otorhinolaryngol, vol. 75, n. 6, dicembre 2009, pp. 806–13, DOI:10.1590/S1808-86942009000600006, PMID 20209279.
Eggermont E, De Boeck K, Small-intestinal abnormalities in cystic fibrosis patients, in Eur. J. Pediatr., vol. 150, n. 12, ottobre 1991, pp. 824–8, DOI:10.1007/BF01954999, PMID 1743211.
Kulczycki LL, Shwachman H, Studies in cystic fibrosis of the pancreas; occurrence of rectal prolapse, in N. Engl. J. Med., vol. 259, n. 9, agosto 1958, pp. 409–12, DOI:10.1056/NEJM195808282590901, PMID 13578072.
Malfroot A, Dab I, New insights on gastro-esophageal reflux in cystic fibrosis by longitudinal follow up, in Arch. Dis. Child., vol. 66, n. 11, novembre 1991, pp. 1339–45, DOI:10.1136/adc.66.11.1339, PMC 1793275, PMID 1755649.
Khoshoo V, Udall JN, Meconium ileus equivalent in children and adults, in Am. J. Gastroenterol., vol. 89, n. 2, febbraio 1994, pp. 153–7, PMID 8304294.
Williams SG, Westaby D, Tanner MS, Mowat AP, Liver and biliary problems in cystic fibrosis, in Br. Med. Bull., vol. 48, n. 4, ottobre 1992, pp. 877–92, PMID 1458306.
Colombo C, Russo MC, Zazzeron L, Romano G, Liver disease in cystic fibrosis, in J. Pediatr. Gastroenterol. Nutr., 43 Suppl 1, luglio 2006, pp. S49–55, DOI:10.1097/01.mpg.0000226390.02355.52, PMID 16819402.
Moran A, Pyzdrowski KL, Weinreb J, et al., Insulin sensitivity in cystic fibrosis, in Diabetes, vol. 43, n. 8, agosto 1994, pp. 1020–6, DOI:10.2337/diabetes.43.8.1020, PMID 8039595.
Alves Cde A, Aguiar RA, Alves AC, Santana MA, Diabetes mellitus in patients with cystic fibrosis, in J Bras Pneumol, vol. 33, n. 2, aprile 2007, pp. 213–21, DOI:10.1590/S1806-37132007000200017, PMID 17724542.
Haworth CS, Selby PL, Webb AK, et al., Low bone mineral density in adults with cystic fibrosis, in Thorax, vol. 54, n. 11, novembre 1999, pp. 961–7, DOI:10.1136/thx.54.11.961, PMC 1745400, PMID 10525552.
(FR) Vandemergel X, Decaux G, [Review on hypertrophic osteoarthropathy and digital clubbing], in Rev Med Brux, vol. 24, n. 2, aprile 2003, pp. 88–94, PMID 12806875.
Pitts-Tucker TJ, Miller MG, Littlewood JM, Finger clubbing in cystic fibrosis, in Arch. Dis. Child., vol. 61, n. 6, giugno 1986, pp. 576–9, DOI:10.1136/adc.61.6.576, PMC 1777828, PMID 3488032.
McCallum TJ, Milunsky JM, Cunningham DL, Harris DH, Maher TA, Oates RD, Fertility in men with cystic fibrosis: an update on current surgical practices and outcomes, in Chest, vol. 118, n. 4, ottobre 2000, pp. 1059–62, DOI:10.1378/chest.118.4.1059, PMID 11035677.
Augarten A, Yahav Y, Kerem BS, et al., Congenital bilateral absence of vas deferens in the absence of cystic fibrosis, in Lancet, vol. 344, n. 8935, novembre 1994, pp. 1473–4, DOI:10.1016/S0140-6736(94)90292-5, PMID 7968122.
Gilljam M, Antoniou M, Shin J, Dupuis A, Corey M, Tullis DE, Pregnancy in cystic fibrosis. Fetal and maternal outcome, in Chest, vol. 118, n. 1, luglio 2000, pp. 85–91, DOI:10.1378/chest.118.1.85, PMID 10893364.
Davies JC, Alton EW, Bush A, Cystic fibrosis, in BMJ, vol. 335, n. 7632, dicembre 2007, pp. 1255–9, DOI:10.1136/bmj.39391.713229.AD, PMC 2137053, PMID 18079549.
Ross LF, Newborn screening for cystic fibrosis: a lesson in public health disparities, in The Journal of Pediatrics, vol. 153, n. 3, settembre 2008, pp. 308–13, DOI:10.1016/j.jpeds.2008.04.061, PMC 2569148, PMID 18718257.
BM Assael, Castellani C, Ocampo MB et al., Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years, in American Journal of Epidemiology, vol. 156, n. 5, settembre 2002, pp. 397–401, DOI:10.1093/aje/kwf064, PMID 12196308.
Stern RC, The diagnosis of cystic fibrosis, in N. Engl. J. Med., vol. 336, n. 7, febbraio 1997, pp. 487–91, DOI:10.1056/NEJM199702133360707, PMID 9017943.
Elias S, Annas GJ, Simpson JL, Carrier screening for cystic fibrosis: implications for obstetric and gynecologic practice, in Am. J. Obstet. Gynecol., vol. 164, n. 4, aprile 1991, pp. 1077–83, PMID 2014829.
Pai VB, Nahata MC, Efficacy and safety of aerosolized tobramycin in cystic fibrosis, in Pediatr. Pulmonol., vol. 32, n. 4, ottobre 2001, pp. 314–27, DOI:10.1002/ppul.1125, PMID 11568993.
Westerman EM, Le Brun PP, Touw DJ, Frijlink HW, Heijerman HG, Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study, in J. Cyst. Fibros., vol. 3, n. 1, marzo 2004, pp. 23–8, DOI:10.1016/j.jcf.2003.12.005, PMID 15463883.
McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB, Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis, in Am. J. Respir. Crit. Care Med., vol. 178, n. 9, novembre 2008, pp. 921–8, DOI:10.1164/rccm.200712-1804OC, PMC 2577727, PMID 18658109.
Hansen CR, Pressler T, Koch C, Høiby N, Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study, in J. Cyst. Fibros., vol. 4, n. 1, marzo 2005, pp. 35–40, DOI:10.1016/j.jcf.2004.09.001, PMID 15752679.
Tan KH, Mulheran M, Knox AJ, Smyth AR, Aminoglycoside prescribing and surveillance in cystic fibrosis, in Am. J. Respir. Crit. Care Med., vol. 167, n. 6, marzo 2003, pp. 819–23, DOI:10.1164/rccm.200109-012CC, PMID 12623858.
Fridell JA, Vianna R, Kwo PY, et al., Simultaneous liver and pancreas transplantation in patients with cystic fibrosis, in Transplant. Proc., vol. 37, n. 8, ottobre 2005, pp. 3567–9, DOI:10.1016/j.transproceed.2005.09.091, PMID 16298663.
Belkin RA, Henig NR, Singer LG, et al., Risk factors for death of patients with cystic fibrosis awaiting lung transplantation, in Am. J. Respir. Crit. Care Med., vol. 173, n. 6, marzo 2006, pp. 659–66, DOI:10.1164/rccm.200410-1369OC, PMC 2662949, PMID 16387803.
Alves CAD, Aguiar RA, Alves AC, Santana MA, Diabetes mellitus in patients with cystic fibrosis, in J Bras Pneumol, vol. 33, n. 2, aprile 2007, pp. 213–21, DOI:10.1590/S1806-37132007000200017, PMID 17724542.
Zirbes J, Milla CE, Cystic fibrosis related diabetes, in Paediatr Respir Rev, vol. 10, n. 3, settembre 2009, pp. 118–23; quiz 123, DOI:10.1016/j.prrv.2009.04.004, PMID 19651382.
Onady GM, Stolfi A, Insulin and oral agents for managing cystic fibrosis-related diabetes, in Gary M Onady (a cura di), Cochrane Database Syst Rev, n. 3, 2005, pp. CD004730, DOI:10.1002/14651858.CD004730.pub2, PMID 16034943.
Conwell LS, Chang AB, Bisphosphonates for osteoporosis in people with cystic fibrosis, in Cochrane Database Syst Rev, n. 4, 2012, pp. CD002010, DOI:10.1002/14651858.CD002010.pub3, PMID 22513903.
Hardin DS, Rice J, Ahn C, et al., Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition, in J. Pediatr., vol. 146, n. 3, marzo 2005, pp. 324–8, DOI:10.1016/j.jpeds.2004.10.037, PMID 15756212.
Marks SC, Kissner DG, Management of sinusitis in adult cystic fibrosis, in Am J Rhinol, vol. 11, n. 1, 1997, pp. 11–4, DOI:10.2500/105065897781446810, PMID 9065342.
Phillipson GT, Petrucco OM, Matthews CD, Congenital bilateral absence of the vas deferens, cystic fibrosis mutation analysis and intracytoplasmic sperm injection, in Hum. Reprod., vol. 15, n. 2, febbraio 2000, pp. 431–5, DOI:10.1093/humrep/15.2.431, PMID 10655317.

oadoi.org

LC. Tsui, Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium., in Hum Mutat, vol. 1, n. 3, 1992, pp. 197-203, DOI:10.1002/humu.1380010304, PMID 1284534.
Araújo FG, Novaes FC, Santos NP, et al., Prevalence of deltaF508, G551D, G542X, and R553X mutations among cystic fibrosis patients in the North of Brazil, in Braz. J. Med. Biol. Res., vol. 38, n. 1, gennaio 2005, pp. 11–5, DOI:10.1590/S0100-879X2005000100003, PMID 15665983.
Hytönen M, Patjas M, Vento SI, et al., Cystic fibrosis gene mutations deltaF508 and 394delTT in patients with chronic sinusitis in Finland, in Acta Otolaryngol., vol. 121, n. 8, dicembre 2001, pp. 945–7, DOI:10.1080/000164801317166835, PMID 11813900.
Bobadilla JL, Macek M, Fine JP, Farrell PM, Cystic fibrosis: a worldwide analysis of CFTR mutations—correlation with incidence data and application to screening, in Hum. Mutat., vol. 19, n. 6, giugno 2002, pp. 575–606, DOI:10.1002/humu.10041, PMID 12007216.
Rowe SM, Miller S, Sorscher EJ, Cystic fibrosis, in The New England Journal of Medicine, vol. 352, n. 19, maggio 2005, pp. 1992–2001, DOI:10.1056/NEJMra043184, PMID 15888700.
EF. McKone, SS. Emerson; KL. Edwards; ML. Aitken, Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study., in Lancet, vol. 361, n. 9370, maggio 2003, pp. 1671-6, DOI:10.1016/S0140-6736(03)13368-5, PMID 12767731.
Flume PA, Mogayzel Jr PJ, Robinson KA, et al., Cystic Fibrosis Pulmonary Guidelines: Pulmonary Complications: Hemoptysis and Pneumothorax, in Am J Respir Crit Care Med, vol. 182, n. 3, marzo 2010, p. 298, DOI:10.1164/rccm.201002-0157OC, PMID 20299528.
Ramsey B, Richardson MA, Impact of sinusitis in cystic fibrosis, in J. Allergy Clin. Immunol., vol. 90, 3 Pt 2, settembre 1992, pp. 547–52, DOI:10.1016/0091-6749(92)90183-3, PMID 1527348.
Kulczycki LL, Shwachman H, Studies in cystic fibrosis of the pancreas; occurrence of rectal prolapse, in N. Engl. J. Med., vol. 259, n. 9, agosto 1958, pp. 409–12, DOI:10.1056/NEJM195808282590901, PMID 13578072.
Colombo C, Russo MC, Zazzeron L, Romano G, Liver disease in cystic fibrosis, in J. Pediatr. Gastroenterol. Nutr., 43 Suppl 1, luglio 2006, pp. S49–55, DOI:10.1097/01.mpg.0000226390.02355.52, PMID 16819402.
Alves Cde A, Aguiar RA, Alves AC, Santana MA, Diabetes mellitus in patients with cystic fibrosis, in J Bras Pneumol, vol. 33, n. 2, aprile 2007, pp. 213–21, DOI:10.1590/S1806-37132007000200017, PMID 17724542.
Augarten A, Yahav Y, Kerem BS, et al., Congenital bilateral absence of vas deferens in the absence of cystic fibrosis, in Lancet, vol. 344, n. 8935, novembre 1994, pp. 1473–4, DOI:10.1016/S0140-6736(94)90292-5, PMID 7968122.
Stern RC, The diagnosis of cystic fibrosis, in N. Engl. J. Med., vol. 336, n. 7, febbraio 1997, pp. 487–91, DOI:10.1056/NEJM199702133360707, PMID 9017943.
Pai VB, Nahata MC, Efficacy and safety of aerosolized tobramycin in cystic fibrosis, in Pediatr. Pulmonol., vol. 32, n. 4, ottobre 2001, pp. 314–27, DOI:10.1002/ppul.1125, PMID 11568993.
Westerman EM, Le Brun PP, Touw DJ, Frijlink HW, Heijerman HG, Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study, in J. Cyst. Fibros., vol. 3, n. 1, marzo 2004, pp. 23–8, DOI:10.1016/j.jcf.2003.12.005, PMID 15463883.
Hansen CR, Pressler T, Koch C, Høiby N, Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study, in J. Cyst. Fibros., vol. 4, n. 1, marzo 2005, pp. 35–40, DOI:10.1016/j.jcf.2004.09.001, PMID 15752679.
Alves CAD, Aguiar RA, Alves AC, Santana MA, Diabetes mellitus in patients with cystic fibrosis, in J Bras Pneumol, vol. 33, n. 2, aprile 2007, pp. 213–21, DOI:10.1590/S1806-37132007000200017, PMID 17724542.
Zirbes J, Milla CE, Cystic fibrosis related diabetes, in Paediatr Respir Rev, vol. 10, n. 3, settembre 2009, pp. 118–23; quiz 123, DOI:10.1016/j.prrv.2009.04.004, PMID 19651382.
Onady GM, Stolfi A, Insulin and oral agents for managing cystic fibrosis-related diabetes, in Gary M Onady (a cura di), Cochrane Database Syst Rev, n. 3, 2005, pp. CD004730, DOI:10.1002/14651858.CD004730.pub2, PMID 16034943.
Conwell LS, Chang AB, Bisphosphonates for osteoporosis in people with cystic fibrosis, in Cochrane Database Syst Rev, n. 4, 2012, pp. CD002010, DOI:10.1002/14651858.CD002010.pub3, PMID 22513903.
Marks SC, Kissner DG, Management of sinusitis in adult cystic fibrosis, in Am J Rhinol, vol. 11, n. 1, 1997, pp. 11–4, DOI:10.2500/105065897781446810, PMID 9065342.

oxfordjournals.org

aje.oxfordjournals.org

BM Assael, Castellani C, Ocampo MB et al., Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years, in American Journal of Epidemiology, vol. 156, n. 5, settembre 2002, pp. 397–401, DOI:10.1093/aje/kwf064, PMID 12196308.

scielo.br

Franco LP, Camargos PA, Becker HM, Guimarães RE, Nasal endoscopic evaluation of children and adolescents with cystic fibrosis, in Braz J Otorhinolaryngol, vol. 75, n. 6, dicembre 2009, pp. 806–13, DOI:10.1590/S1808-86942009000600006, PMID 20209279.

science.ca

science.ca Profile : Lap-Chee Tsui

sibioc.it

Società Italiana per lo Studio della Fibrosi Cistica (SIFC), Analisi genetica in Fibrosi Cistica – Consensus 2019 (PDF).

sifc.it

Società Italiana Fibrosi Cistica, su sifc.it.

testfibrosicistica.it

1 su 30 e non lo sai - Test fibrosi cistica - Fondazione per la Ricerca sulla Fibrosi Cistica, su testfibrosicistica.it.

web.archive.org

Cystic Fibrosis Foundation – Genetic Carrier Testing Archiviato il 23 marzo 2010 in Internet Archive. Updated 07/09/07
P Farrel, S Joffe,L Foley,GJ Canny,P Mayne,M Rosenber, Irish Medical Journal, vol. 100, n. 8, settembre 2007, pp. 557–60, https://web.archive.org/web/20131203001750/http://www.imj.ie//ViewArticleDetails.aspx?ArticleID=2497 (archiviato dall'url originale il 3 dicembre 2013).
CF worse for women 'due to effect of oestregen', in The Irish Times, 8 agosto 2010. URL consultato il 1º maggio 2019 (archiviato dall'url originale il 14 marzo 2011).
(FR) P Fanen e A Hasnain, Mucoviscidose et Gène CFTR, su atlasgeneticsoncology.org, Atlas Genet Cytogenet Oncol Haematol, settembre 2001. URL consultato il 12 giugno 2008 (archiviato dall'url originale il 14 giugno 2008).
O'Malley CA, Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist (PDF), in Respir Care, vol. 54, n. 5, maggio 2009, pp. 641–57, DOI:10.4187/aarc0446, PMID 19393108. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 15 luglio 2011).
Makker K, Agarwal A, Sharma R, Oxidative stress & male infertility (PDF), in Indian J. Med. Res., vol. 129, n. 4, aprile 2009, pp. 357–67, PMID 19535829. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 5 luglio 2010).
Ratjen FA, Cystic fibrosis: pathogenesis and future treatment strategies (PDF), in Respir Care, vol. 54, n. 5, maggio 2009, pp. 595–605, DOI:10.4187/aarc0427, PMID 19393104. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 15 luglio 2011).
Fondazione per la Ricerca sulla Fibrosi Cistica, Il test per il portatore sano di fibrosi cistica (PDF), su fibrosicisticaricerca.it. URL consultato il 22 maggio 2023 (archiviato dall'url originale il 22 maggio 2023).
What is the life expectancy for people who have CF (in the United States)?, su cff.org, Cystic Fibrosis Foundation, 2008. URL consultato il 14 marzo 2010 (archiviato dall'url originale il 25 ottobre 2006).
Canadian Cystic Fibrosis Patient Data Registry Report (PDF), su cysticfibrosis.ca, Canadian Cystic Fibrosis Foundation, 2007. URL consultato il 14 marzo 2010 (archiviato dall'url originale il 15 luglio 2010).
Cystic Fibrosis Patient Registry Annual Data Report 2009 (PDF), su cff.org, Cystic Fibrosis Foundation, 2009 (archiviato dall'url originale il 5 gennaio 2012).
(RU) Copia archiviata, su mucoviscidos.ru. URL consultato il 1º novembre 2012 (archiviato dall'url originale il 29 marzo 2009).